← FDA DRUG APPROVALS

FDA ANDA · ANDA076484

CIPROFLOXACIN

Sponsor: FRESENIUS KABI USA

APPLICATION
ANDA076484
TYPE
ANDA
ORIGINAL APPROVAL
2006-08-28
LATEST ACTION
2006-08-28
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

CIPROFLOXACINDiscontinued
CIPROFLOXACIN 200MG/20ML (10MG/ML) · INJECTABLE · INJECTION
CIPROFLOXACINDiscontinued
CIPROFLOXACIN 400MG/40ML (10MG/ML) · INJECTABLE · INJECTION

Approval history

2006-08-28OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →